EGFRvIII peptide (PEPvIII)

This synthetic peptide corresponds to the EGFRvIII neoantigen, a tumor-specific target in glioblastoma, and is presented by MHC class I and II molecules. It serves as a critical reagent for immunological research, enabling in vitro T-cell assays and in vivo studies of vaccine and adoptive therapy efficacy.